There has been growing concern about the safety and effectiveness of some medical devices in the United States once they are approved by the Food and Drug Administration. In an effort to address those concerns, the FDA formed a partnership with the medical and research community and the device manufacturer to help monitor how a recently approved aortic valve performed in patients across the country. Catherine Dolf has more in this week’s JAMA Report.